Literature DB >> 2088202

Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin.

S Flor1, D R Guay, J A Opsahl, K Tack, G R Matzke.   

Abstract

The effects of 15- and 5-ml doses of magnesium-aluminum hydroxide (MAH) and calcium carbonate (CC) antacids, respectively, on the bioavailability of ofloxacin after single oral 400-mg doses of ofloxacin were investigated in a 32-subject, randomized, crossover, open-label study. On four separate occasions, subjects received ofloxacin alone or antacid 24 h before, 2 h before, or 2 h after ofloxacin administration (n = 16 for each antacid). CC administration had no significant effect on the rate and extent of ofloxacin absorption regardless of the timing of antacid administration. A small but significant negative effect of MAH administration 2 h before ofloxacin administration was noted as evidenced by area under the curve and peak concentration in plasma data. Simultaneous administration of ofloxacin with either antacid was not investigated in this study. It appears that MAH and CC antacids in the doses used in this study generally do not interfere in a clinically significant manner with the bioavailability of ofloxacin, provided that an interval of at least 2 h separates the administration of these products.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2088202      PMCID: PMC172079          DOI: 10.1128/AAC.34.12.2436

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin.

Authors:  D E Nix; W A Watson; L Handy; R W Frost; D L Rescott; H R Goldstein
Journal:  Pharmacotherapy       Date:  1989       Impact factor: 4.705

2.  Sucralfate reduces the gastrointestinal absorption of norfloxacin.

Authors:  S H Parpia; D E Nix; L G Hejmanowski; H R Goldstein; J H Wilton; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

3.  Effects of antacids and dialysate dwell times on multiple-dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis.

Authors:  T A Golper; A I Hartstein; V H Morthland; J M Christensen
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

4.  Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin.

Authors:  D E Nix; W A Watson; M E Lener; R W Frost; G Krol; H Goldstein; J Lettieri; J J Schentag
Journal:  Clin Pharmacol Ther       Date:  1989-12       Impact factor: 6.875

5.  Pharmacokinetics of ofloxacin. An overview.

Authors:  S Flor
Journal:  Am J Med       Date:  1989-12-29       Impact factor: 4.965

Review 6.  Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Monk; D M Campoli-Richards
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

7.  Inhibition of enoxacin absorption by antacids or ranitidine.

Authors:  T H Grasela; J J Schentag; A J Sedman; J H Wilton; D J Thomas; R W Schultz; M E Lebsack; A W Kinkel
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

8.  [Ofloxacin treatment in nephrologic problem patients with various degrees of chronic renal failure (including dialysis treatment). Preliminary results].

Authors:  W Schulz; A Dörfler
Journal:  Infection       Date:  1986       Impact factor: 3.553

Review 9.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  9 in total
  26 in total

1.  Effect of calcium supplements on the oral bioavailability of moxifloxacin in healthy male volunteers.

Authors:  H Stass; C Wandel; H Delesen; J G Möller
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium.

Authors:  S Lober; S Ziege; M Rau; G Schreiber; A Mignot; P Koeppe; H Lode
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

3.  Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.

Authors:  H Stass; M F Böttcher; K Ochmann
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

4.  Effects of antacids, ferrous sulfate, and ranitidine on absorption of DR-3355 in humans.

Authors:  K Shiba; O Sakai; J Shimada; O Okazaki; H Aoki; H Hakusui
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

5.  Effects of two cations on gastrointestinal absorption of ofloxacin.

Authors:  M Martínez Cabarga; A Sánchez Navarro; C I Colino Gandarillas; A Domínguez-Gil
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

6.  Clinical significance of pharmacokinetic drug interactions with over-the-counter (OTC) drugs.

Authors:  P K Honig; B K Gillespie
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

Review 7.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 8.  Fluoroquinolones: interaction profile during enteral absorption.

Authors:  K M Deppermann; H Lode
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 9.  Drug interactions with quinolone antibacterials.

Authors:  J R Brouwers
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

10.  Effect of magnesium complexation by fluoroquinolones on their antibacterial properties.

Authors:  S Lecomte; M H Baron; M T Chenon; C Coupry; N J Moreau
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.